GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » Revenue

Geratherm Medical AG (XTER:GME) Revenue : €18.90 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG Revenue?

Geratherm Medical AG's revenue for the six months ended in Jun. 2024 was €8.94 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €18.90 Mil. Geratherm Medical AG's Revenue per Share for the six months ended in Jun. 2024 was €1.88. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €3.72.

Warning Sign:

Geratherm Medical AG revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Geratherm Medical AG was -24.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -10.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Geratherm Medical AG's highest 3-Year average Revenue per Share Growth Rate was 20.70% per year. The lowest was -10.10% per year. And the median was 5.20% per year.


Geratherm Medical AG Revenue Historical Data

The historical data trend for Geratherm Medical AG's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geratherm Medical AG Revenue Chart

Geratherm Medical AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.34 28.08 24.64 27.44 22.30

Geratherm Medical AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.06 14.38 12.34 9.96 8.94

Competitive Comparison of Geratherm Medical AG's Revenue

For the Medical Devices subindustry, Geratherm Medical AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Geratherm Medical AG's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's Revenue distribution charts can be found below:

* The bar in red indicates where Geratherm Medical AG's Revenue falls into.



Geratherm Medical AG Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €18.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Geratherm Medical AG  (XTER:GME) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Geratherm Medical AG Revenue Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Geratherm Medical AG Business Description

Traded in Other Exchanges
Address
Fahrenheitstrasse 1, Geratal, DEU, 99331
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
Executives
Dr. Gert Frank Supervisory Board
Christian Frick Board of Directors